share_log

SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6

Benzinga Real-time News ·  Nov 14, 2022 13:46

SVB Leerink analyst Mani Foroohar maintains Abeona Therapeutics (NASDAQ:ABEO) with a Market Perform and raises the price target from $5 to $6.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment